Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Response to: Â Correspondence on â Efficacy and safety of brodalumab, an anti-IL17RA monoclonal antibody, in patients with axial spondyloarthritis: 16-week results from a randomised, placebo-controlled, phase 3 trial by Zhao and Huang
- Authors
- Wei, James Cheng-Chung; Kim, Tae Hwan; Kishimoto, Mitsumasa; Ogusu, Naoki; Jeong, Haeyoun; Kobayashi, Shigeto
- Issue Date
- Jun-2023
- Publisher
- BMJ Publishing Group
- Keywords
- ankylosing; biological therapy; inflammation; spondylitis; therapeutics
- Citation
- Annals of the Rheumatic Diseases, v.82, no.7, pp.1 - 2
- Indexed
- SCIE
SCOPUS
- Journal Title
- Annals of the Rheumatic Diseases
- Volume
- 82
- Number
- 7
- Start Page
- 1
- End Page
- 2
- ISSN
- 0003-4967
- Abstract
- [No abstract available]
- Files in This Item
- Appears in
Collections - 서울 의과대학 > 서울 내과학교실 > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Related Researcher
- Kim, Tae Hwan
- COLLEGE OF MEDICINE (DEPARTMENT OF INTERNAL MEDICINE)